Skip to main content
OpenTrials

Clinical trial condition

Triple Negative Breast Cancer

Explore clinical trials studying Triple Negative Breast Cancer. Study availability and eligibility vary by location and protocol.

298 public trials 111 recruiting studies
Refine in advanced search Browse all conditions

Triple Negative Breast Cancer trial results

Active, not recruiting

PAveMenT: Palbociclib and Avelumab in Metastatic AR+ Triple Negative Breast Cancer

NCT04360941

Conditions
Breast Diseases, Breast Neoplasms, ER+ Breast Cancer, +10 more
Locations
  • The Christie NHS Foundation Trust Manchester, Greater Manchester, United Kingdom
  • Addenbrooke's Hospital Cambridge University Hospitals NHS Foundation Trust Cambridge, United Kingdom
  • Beatson West of Scotland Cancer Centre Glasgow, United Kingdom
  • Hope Clinical Trials Cancer Centre Leicester, United Kingdom
View Trial Details
Active, not recruiting

A Study to Investigate APL-5125 in Adults With Advanced Solid Tumors

NCT06399757

Conditions
Adenocarcinoma, Adenocarcinoma, Mucinous, Adnexal Diseases, +46 more
Locations
  • City of Hope Duarte, California, United States
  • City of Hope Orange County Lennar Foundation Cancer Center Irvine, California, United States
  • Florida Cancer Specialists & Research Institute Sarasota, Florida, United States
  • University of Michigan Ann Arbor, Michigan, United States
View Trial Details
Active, not recruiting

A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations

NCT07038369

Conditions
Adnexal Diseases, Advanced Solid Tumors, Breast Cancer, +46 more
Locations
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Florida Cancer Specialists & Research Institute - Lake Mary Lake Mary, Florida, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Washington University St Louis, Missouri, United States
View Trial Details
Active, not recruiting

Cardiac Outcomes With Near-Complete Estrogen Deprivation

NCT05309655

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +7 more
Locations
  • Duke Cancer Center Durham, North Carolina, United States
  • Wake Forest Baptist Comprehensive Cancer Center Winston-Salem, North Carolina, United States
  • Virginia Commonwealth University Massey Cancer Center Richmond, Virginia, United States
View Trial Details
Active, not recruiting

Study Comparing the Standard Administration of IO Versus the Same IO Administered Each 3 Months in Patients in Response After 6 Months of Standard IO

NCT05078047

Conditions
Adenocarcinoma, Basal Cell Carcinoma, Breast Diseases, +69 more
Locations
  • Institut de cancérologie de l'Ouest Angers, France
  • Clinique Sainte Catherine Avignon, France
  • Centre Hospitalier de la Côte Basque Bayonne, France
  • CHU Bordeaux - Hôpial Saint André Bordeaux, France
View all 33 locations
View Trial Details
Active, not recruiting

Pre-op Pembro + Radiation Therapy in Breast Cancer (P-RAD)

NCT04443348

Conditions
Biopsy-proven, Positive Lymph Node(s), Breast Diseases, Breast Neoplasms, +7 more
Locations
  • Sibley Memorial Hospital Washington D.C., District of Columbia, United States
  • Johns Hopkins Baltimore, Maryland, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Active, not recruiting

Safety and Preliminary Effectiveness of BNT327, an Investigational Therapy for Breast Cancer, When Given in Combination With Chemotherapy

NCT06449222

Conditions
Breast Diseases, Breast Neoplasms, Locally Advanced Breast Cancer, +7 more
Locations
  • Beverly Hills Cancer Center Beverly Hills, California, United States
  • Valkyrie Clinical Trials Los Angeles, California, United States
  • Stanford University School of Medicine - Stanford Cancer Institute (SCI) - Stanford Women's Cancer Center Palo Alto, California, United States
  • Saint John's Health Center - John Wayne Cancer Institute (JWCI) Santa Monica, California, United States
View all 31 locations
View Trial Details
Active, not recruiting

ASTEROID: A Trial of ASTX660 in Combination With Pembrolizumab

NCT05082259

Conditions
Advanced Cancer, Breast Diseases, Breast Neoplasms, +18 more
Locations
  • Cambridge University Hospitals NHS Trust Cambridge, United Kingdom
  • The Royal Marden NHS Foundation Trust - Drug Development Unit Sutton, United Kingdom
  • The Royal Marsden NHS Foundation Trust - Breast Unit Sutton, United Kingdom
View Trial Details

Related conditions